Senator Kennedy Questions PBMs on Drug Pricing and Vertical Integration

Vertical Integration in the PBM Market

• 🎯 It is stated that 80% of the PBM market is controlled by three vertically integrated companies.
• 💡 Research suggests that this vertical integration leads to higher Medicare Part D premiums for consumers.

Fiduciary Responsibility of PBMs

• ⚖️ Professor Sud suggests that PBMs should act as fiduciaries to both the plan and its members.
• ⚠️ When the interests of the plan and members diverge, PBMs should ultimately be fiduciaries to the members.
• ❓ Senator Kennedy questions the definition of a fiduciary, emphasizing a legal obligation to give the client the best advice and act in their best interest.

Proposed Solutions for Lower Drug Prices

• 🔍 Two key actions proposed to fix PBMs and lower consumer prices are price transparency and fiduciary responsibility.
• 🧩 Price transparency reveals who is overcharging, while fiduciary responsibility allows legal recourse if consumers are being harmed.
• 🚫 Banning specific practices is seen as less effective, as new issues may arise (whack-a-mole).

Rebate Pass-Through to Patients

• 💸 A significant proposal is the pass-through of rebates to patients at the point of sale.
• 📉 Currently, patients pay cost-sharing on the list price of a drug, not the post-rebate price.
• 📈 Passing through rebates would immediately lower patient out-of-pocket costs, especially for expensive medications like cancer drugs.
• ⚠️ It is suggested that PBMs encourage manufacturers to inflate list prices to increase their own rebate amounts, which is alleged to be illegal.